![]() |
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
Innovative Medical |
---|---|
Information provided by: | Innovative Medical |
ClinicalTrials.gov Identifier: | NCT00483795 |
To evaluate corneal staining after contact lens instillation with two different multi purpose solutions.
Condition | Intervention | Phase |
---|---|---|
Corneal Staining |
Drug: sodium citrate, sodium chloride, sodium borate, propylene glycol. citrate, tetronic 1304, AMP 95 |
Phase IV |
Study Type: | Interventional |
Study Design: | Randomized, Single Blind, Active Control, Parallel Assignment |
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Inclusion Criteria:
Exclusion Criteria:
United States, Pennsylvania | |
Hazleton Eye Specialists | |
Hazleton, Pennsylvania, United States, 18202 |
Principal Investigator: | Thomas Kislan, OD | Hazleton Eye Specialists |
Study ID Numbers: | 5308 |
Study First Received: | June 1, 2007 |
Last Updated: | July 23, 2007 |
ClinicalTrials.gov Identifier: | NCT00483795 |
Health Authority: | United States: Institutional Review Board |
Citric Acid |